Common complications after laryngeal cancer surgery

Laryngeal cancer is one of the most common head and neck malignant tumors, accounting for 1% to 5% of all malignant tumors in the body. The high-incidence area in my country is the Northeast, where the incidence rate accounts for 5% to 8% of all malignant tumors in the body. It has a great impact on human health. Surgery is usually the first choice for laryngeal cancer treatment. So, what are the common complications after laryngeal cancer surgery?

These are usually complications that occur after surgery: such as tube blockage, tube dislocation, aspiration, misplacement, nausea, vomiting, diarrhea, water and electrolyte imbalance, nasal infection, bad breath, etc.

Subcutaneous emphysema is more likely to occur in patients after tracheotomy due to coughing or a large tracheal incision while the skin incision is relatively small and the cannula is thin. When subcutaneous emphysema occurs, the scope, degree and occurrence of subcutaneous emphysema should be closely observed. After appropriate cough suppressants are given, most of it can be absorbed by itself. In severe cases, use adhesive tape to compress or perform subcutaneous puncture to exhaust.

After understanding the complications after laryngeal cancer surgery, patients must be very cautious in choosing the treatment method. At present, tumor biotherapy technology is the best choice for patients. Combined tumor biotherapy after laryngeal cancer surgery can accurately kill residual cancer cells after surgery, prevent the occurrence of postoperative complications, enhance the patient's immunity, and help patients recover as soon as possible.

At the same time, the advantages of tumor biological treatment for laryngeal cancer are incomparable to conventional treatment methods.

1. It can effectively remove residual tumor cells and tiny lesions after laryngeal cancer surgery, radiotherapy and chemotherapy, and prevent the recurrence and metastasis of laryngeal cancer.

2. It can enhance the sensitivity of laryngeal cancer to radiotherapy and reduce the toxic side effects of radiotherapy; resist the immunosuppressive effects of chemotherapy drugs, enhance the sensitivity to chemotherapy drugs, and improve the effectiveness of chemotherapy.

3. For patients with advanced laryngeal cancer who have lost the opportunity for surgery and for whom radiotherapy and chemotherapy are ineffective, tumor biological treatment is the only option. The treatment is painless and can quickly relieve symptoms. Patients can achieve long-term survival with the tumor, prolonging their life span and improving their quality of life.